Belmore Neidrauer is unique in that it is devoted entirely to IP litigation, with 90% of that being devoted to pharmaceutical litigation on behalf of innovators. "It is all very high-stakes, high-profile and high-end," confirms a peer. "It's a boutique but it's actually a bigger group than some of the IP departments of other firms." A client testifies, "The lean and efficient structure of this firm results in cost-effective work for us. Their deep insight and experience on pharma patent litigation is one of the factors for our long-lasting work relationship. They are prompt, realistic, proactive, and able to recommend odd and creative strategy based on less-known principles or regulations." The firm augmented its bench within the past year with the addition of former Norton Rose Fulbright partner Jason Markwell, a celebrated figure in the pharmaceutical community."